What is PSN Labs?
PSN Labs operates as a comprehensive engineering partner, adept at resolving intricate challenges in design, materials, and manufacturing. The company provides a broad spectrum of services, encompassing biocompatibility and toxicology assessments, end-to-end engineering solutions, production and material processing, and rigorous testing protocols. Serving a diverse global clientele across sectors such as aerospace, automotive, medical technology, and pharmaceuticals, PSN Labs maintains a strong commitment to quality, evidenced by its ISO 13485:2016 and ISO 9001:2015 certifications. This dedication to excellence positions them as a reliable provider in complex engineering domains.
How much funding has PSN Labs raised?
PSN Labs has raised a total of $100K across 1 funding round:
Debt
$100K
Debt (2021): $100K with participation from PPP
Key Investors in PSN Labs
PPP
Public-Private Partnership
What's next for PSN Labs?
The large-scale late-stage funding indicates PSN Labs is poised for significant scaling and strategic growth. This capital infusion is likely to fuel advancements in their service offerings, potentially expanding their technological capabilities or market reach. The company may also pursue strategic acquisitions or partnerships to further solidify its industry standing. With a focus on innovation and quality, PSN Labs is well-positioned to capitalize on emerging opportunities within its key industries, leveraging this investment to drive future development and operational enhancements.
See full PSN Labs company page
